A phase II study of epirubicin in patients with advanced adenocarcinoma of the pancreas.
Aoki K, Shimada Y, Okazaki N, Tajiri H, Nose H, Okada S, Shirao K, Yokota T, Yoshida S, Saitoh D, et al.
Aoki K, et al. Among authors: okada s.
Eur J Cancer. 1992;28A(8-9):1590. doi: 10.1016/0959-8049(92)90563-h.
Eur J Cancer. 1992.
PMID: 1515280
Clinical Trial.
No abstract available.